Arkolith/Insider Trading/KPRX/Form 4

Tyle Praveen

DirectorKIORA PHARMACEUTICALS INC (KPRX) · full profile →Form 4 · filed Aug 19, 2024
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2024Buy(P)5K$3.96$20K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001372514-24-000109) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML